References
- EttingerSStanakMSzymańskiPWearable cardioverter defibrillators for the prevention of sudden cardiac arrest: a health technology assessment and patient focus group studyMed Devices20171410257271
- DrummondMFSchwartzJSJonssonBKey principles for the improved conduct of health technology assessments for resource allocation decisionsInt J Technol Assess Health Care2008243244258 discussion 362–36818601792
- EpsteinAEAbrahamWTBiancoNRWearable cardioverter-defibrillator use in patients perceived to be at high risk early post-myocardial infarctionJ Am Coll Cardiol201362212000200723916930
- ZishiriETWilliamsSCroninEMEarly risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillatorCirc Arrhythm Electrophysiol20136111712823275233
- ChungMKSzymkiewiczSJShaoMAggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survivalJ Am Coll Cardiol201056319420320620738
- DunckerDHaghikiaAKönigTRisk for ventricular fibrillation in peripartum cardiomyopathy with severely reduced left ventricular function-value of the wearable cardioverter/defibrillatorEur J Heart Fail201416121331133625371320
- KondoYLinhartMAndriéRPSchwabJOUsefulness of the wearable cardioverter defibrillator in patients in the early post-myocardial infarction phase with high risk of sudden cardiac death: a single-center European experienceJ Arrhythm201531529329526550085
- KutyifaVMossAJKleinHUse of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)Circulation2015132171613161926316618
References
- European network for Health Technology Assessment (EUnetHTA)COMPARATORS & COMPARISONS: direct and indirect comparisons2015 [cited March 17, 2018. Available from: https://www.eunethta.eu/wp-content/uploads/2018/03/Direct_comparators_comparisons.pdfAccessed April 24, 2018
- European network for Health Technology Assessment (EUnetHTA)Rapid Relative Effectiveness Assessments422016 [cited March 17, 2018]. Available from: http://meka.thl.fi/htacore/ViewApplication.aspx?id=25468 Accessed April 24, 2018
- PicciniJPSrAllenLAKudenchukPJWearable cardioverter-defibrillator therapy for the prevention of sudden cardiac death: a Science advisory from the American Heart AssociationCirculation2016133171715172727022063
- BlueCross BlueShield Association. Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatmentTEC Assessment ProgramChicago, ILBlue Cross Blue Shield Association (BCBSA)2010
- European network for Health Technology Assessment (EUnetHTA)Internal validity of non-randomised studies (NRS) on interventions2015 [cited March 17, 2018] Available from: https://www.eunethta.eu/wp-content/uploads/2018/01/Internal-validity-of-non-randomised-studies-NRS-on-interventions_Guideline_Final-Jul-2015.pdfAccessed April 24, 2018
- BalshemHHelfandMSchünemannHJGRADE guidelines: 3. Rating the quality of evidenceJ Clin Epidemiol201164440140621208779
- SchünemannHBrożekJGuyattGOxmanAGRADE Handbook2013 Available from: http://gdt.guidelinedevelopment.org/app/handbook/handbook.htmlAccessed April 24, 2018
- DurandMAChantlerTPrinciples of Social ResearchLondonOpen University Press2014